Product Information
UZEDY ER 50 MG/0.14 ML SYRINGE is a brand product labeled by Teva Pharmaceuticals USA Inc., priced at $9451.0124 per ML under NDC 51759030510. Its NADAC has been published 36 times since Oct 22, 2025.
The High Outlier badge above means this manufacturer's average price in the risperidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/.14mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
51759030510
Classification
Brand
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
SUBCUTANEOUS
Last Updated
1/1/2026
Active Ingredients
RISPERIDONEApproval Type
New Drug (NDA)
FDA Application
NDA213586On Market Since
5/1/2023
Pharmacological Classes
Price Statistics
The NADAC for UZEDY ER 50 MG/0.14 ML SYRINGE has been published 36 times since Oct 22, 2025, and over the history we have for it it has risen 3.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9451.0124 per ML |
|---|---|
| All-time high | $9451.0124 (Jun 24, 2026) |
| All-time low | $9087.5119 (Dec 17, 2025) |
| 52-week high | $9451.0124 |
| 52-week low | $9087.5119 |
| Median price | $9451.0124 |
| Average price | $9346.2449 |
| Largest weekly change | +4.0% (Jan 7, 2026) |
| Weeks tracked | 36 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the risperidone market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of UZEDY ER 50 MG/0.14 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for UZEDY ER 50 MG/0.14 ML SYRINGE, manufactured by Teva Pharmaceuticals USA Inc., is $9451.0124 per ML (NDC 51759030510), effective Jun 24, 2026.
How has the price of UZEDY ER 50 MG/0.14 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for UZEDY ER 50 MG/0.14 ML SYRINGE has risen 3.7%. It has been tracked across 36 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for UZEDY ER 50 MG/0.14 ML SYRINGE?
Since Oct 22, 2025, the NADAC for UZEDY ER 50 MG/0.14 ML SYRINGE has ranged from a low of $9087.5119 (Dec 17, 2025) to a high of $9451.0124 (Jun 24, 2026), with a median of $9451.0124 per ML.
Are there cheaper alternatives to UZEDY ER 50 MG/0.14 ML SYRINGE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of UZEDY ER 50 MG/0.14 ML SYRINGE, so no direct lower-cost alternative is listed.
Who manufactures UZEDY ER 50 MG/0.14 ML SYRINGE?
UZEDY ER 50 MG/0.14 ML SYRINGE (NDC 51759030510) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification